XML 64 R79.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies and Certain Commitments (Actions In Which We Are The Plaintiff) (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 29, 2020
Patents
Mar. 29, 2020
Patents
Jan. 31, 2020
Patents
Mar. 31, 2019
Patents
Dec. 31, 2018
Patents
Jun. 30, 2018
Patents
Jan. 31, 2018
Patents
Oct. 31, 2017
Patents
Mar. 31, 2017
Patents
Aug. 31, 2015
Patents
Mar. 29, 2020
Patents
Apr. 30, 2017
Patents
Defendant
Dec. 31, 2014
Patents
Precedex Premix [Member] | Hospira Versus Amneal Pharmaceuticals LLC [Member] | Pending Litigation [Member]                          
Gain Contingencies [Line Items]                          
Number of patents allegedly not infringed upon                         1
Precedex Premix [Member] | Hospira Versus Amneal Pharmaceuticals LLC [Member] | Settled Litigation [Member]                          
Gain Contingencies [Line Items]                          
Number of patents infringed upon             1            
Number of allegedly not infringed upon patents due to expire March 2019       1                  
Number of patents not infringed upon             3            
Precedex Premix [Member] | Hospira Versus Fresenius Kabj USA LLC [Member] | Settled Litigation [Member]                          
Gain Contingencies [Line Items]                          
Number of patents not infringed upon 2       2                
Number of patents found not infringed upon subsequently appealed                     1    
Precedex Premix [Member] | Hospira Versus Par [Member] | Settled Litigation [Member]                          
Gain Contingencies [Line Items]                          
Number of patents allegedly not infringed upon             4     4      
Precedex Premix [Member] | Hospira Versus Par Steril Products, LLC, Gland Pharma Limited And Jiangsu Hengrui Medicine Co. [Member] | Settled Litigation [Member]                          
Gain Contingencies [Line Items]                          
Number of patents not infringed upon   3                      
Patent Infringement [Member]                          
Gain Contingencies [Line Items]                          
Number of patents which the Patent Trial and Appeal Board refused to initiate proceedings               2          
Patent Infringement [Member] | Judicial Ruling [Member]                          
Gain Contingencies [Line Items]                          
Number of patents infringed upon           1              
Patent Infringement [Member] | Pfizer Versus Ajanta [Member] | Pending Litigation [Member]                          
Gain Contingencies [Line Items]                          
Number of patents allegedly infringed upon       2                  
Patent Infringement [Member] | Pfizer Versus Generic Companies [Member] | Pending Litigation [Member]                          
Gain Contingencies [Line Items]                          
Number of patents allegedly infringed upon       2                  
Patent Infringement [Member] | Pfizer Versus Viwit Pharmaceutical Co. Ltd. [Member] | Pending Litigation [Member]                          
Gain Contingencies [Line Items]                          
Number of patents allegedly infringed upon     3                    
Patent Infringement [Member] | Xeljanz [Member] | Pfizer Versus Zydus [Member] | Pending Litigation [Member]                          
Gain Contingencies [Line Items]                          
Number of patents allegedly infringed upon                 3        
Patent Infringement [Member] | Eliquis [Member] | Pfizer and BMS Versus Several Generic Manufacturers [Member] | Pending Litigation [Member]                          
Gain Contingencies [Line Items]                          
Number of patents allegedly infringed upon                       3  
Number of defendants | Defendant                       25  
Number of patents allegedly infringed upon due to expire December 2019                       1